Zkusit zdarma
Vera Therapeutics, Inc.

Vera Therapeutics, Inc.

VERA
Cena:
$ 34.04
-0.31 (-0.90%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

7:30 07-05-2026

U.S. Food and Drug Administration (FDA) granted priority review to Biologics License Application (BL...

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference

Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference

7:30 04-05-2026

BRISBANE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a biotech...

JPMorgan Chase & Co. Sells 228,182 Shares of Vera Therapeutics, Inc. $VERA

JPMorgan Chase & Co. Sells 228,182 Shares of Vera Therapeutics, Inc. $VERA

5:03 07-04-2026

JPMorgan Chase and Co. cut its position in shares of Vera Therapeutics, Inc. (NASDAQ: VERA) by 73.5%...

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

7:30 25-03-2026

BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a biote...

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Moderate Buy” by Brokerages

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Moderate Buy” by Brokerages

2:30 22-03-2026

Shares of Vera Therapeutics, Inc. (NASDAQ: VERA - Get Free Report) have received a consensus recomme...

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

13:49 20-03-2026

Integral Health bought 100,000 Vera Therapeutics shares for an estimated $3.55 million in the fourth...

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

14:03 16-03-2026

Eversept Partners added 264,468 shares of Vera Therapeutics in the fourth quarter; the estimated tra...

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision

This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision

10:36 13-03-2026

Deerfield Management Company bought 418,538 Vera Therapeutics shares in the fourth quarter; the esti...

Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

15:05 06-03-2026

Vera Therapeutics, Inc. (VERA) Presents at TD Cowen 46th Annual Health Care Conference Transcript...

Vera Therapeutics Appoints Christopher Hite to Board of Directors

Vera Therapeutics Appoints Christopher Hite to Board of Directors

9:00 05-03-2026

BRISBANE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a biote...

Vera Therapeutics to Participate at Upcoming Investor Conferences

Vera Therapeutics to Participate at Upcoming Investor Conferences

8:00 24-02-2026

BRISBANE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late c...

Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)

Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)

16:00 20-02-2026

Vera Therapeutics is downgraded from 'Strong Buy' to 'Hold' due to intensifying competition in the I...

Comparing Vera Therapeutics (NASDAQ:VERA) & Inventiva (NASDAQ:IVA)

Comparing Vera Therapeutics (NASDAQ:VERA) & Inventiva (NASDAQ:IVA)

1:18 05-02-2026

Inventiva (NASDAQ: IVA - Get Free Report) and Vera Therapeutics (NASDAQ: VERA - Get Free Report) are...

Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer

Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer

7:30 28-01-2026

BRISBANE, Calif., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late c...

SG Americas Securities LLC Takes $911,000 Position in Vera Therapeutics, Inc. $VERA

SG Americas Securities LLC Takes $911,000 Position in Vera Therapeutics, Inc. $VERA

6:23 20-01-2026

SG Americas Securities LLC acquired a new stake in shares of Vera Therapeutics, Inc. (NASDAQ: VERA) ...

Wall Street Analysts See a 53.05% Upside in Vera Therapeutics (VERA): Can the Stock Really Move This High?

Wall Street Analysts See a 53.05% Upside in Vera Therapeutics (VERA): Can the Stock Really Move This High?

10:55 14-01-2026

The consensus price target hints at a 53.1% upside potential for Vera Therapeutics (VERA). While emp...

Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

20:15 13-01-2026

Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript...

Why Vera Therapeutics Stock Zoomed Higher Today

Why Vera Therapeutics Stock Zoomed Higher Today

19:21 07-01-2026

The biotech has formally submitted a biologics license application to the FDA for its kidney disease...

FDA Fast-Tracks Vera's At-Home Kidney Drug

FDA Fast-Tracks Vera's At-Home Kidney Drug

12:29 07-01-2026

Vera Therapeutics Inc. (NASDAQ: VERA) stock rose Wednesday after the U.S. Food and Drug Administrati...

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy

7:30 07-01-2026

Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for At...

close

VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

06-02-2026
BRISBANE, CALIF., FEB. 06, 2026 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS ANNOUNCES APPOINTMENT OF MATT SKELTON TO CHIEF COMMERCIAL OFFICER

28-01-2026
BRISBANE, CALIF., JAN. 28, 2026 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-01-2026
BRISBANE, CALIF., JAN. 09, 2026 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS ANNOUNCES U.S. FDA GRANTED PRIORITY REVIEW TO BIOLOGICS LICENSE APPLICATION FOR ATACICEPT FOR TREATMENT OF ADULTS WITH IGA NEPHROPATHY

07-01-2026
VERA THERAPEUTICS ANNOUNCES U.S. FDA GRANTED PRIORITY REVIEW TO BIOLOGICS LICENSE APPLICATION FOR AT...
Více zde

VERA THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF CLASS A COMMON STOCK

09-12-2025
BRISBANE, CALIF., DEC. 09, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (“VERA THERAPEUTICS”...
Více zde

VERA THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF CLASS A COMMON STOCK

08-12-2025
BRISBANE, CALIF., DEC. 08, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (“VERA THERAPEUTICS”...
Více zde

VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-12-2025
BRISBANE, CALIF., DEC. 05, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS APPOINTS VETERAN BIOTECH EXECUTIVE JAMES R. MEYERS TO ITS BOARD OF DIRECTORS

26-11-2025
BRISBANE, CALIF., NOV. 26, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES

24-11-2025
BRISBANE, CALIF., NOV. 24, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS TO PARTICIPATE IN THE TD COWEN IMMUNOLOGY & INFLAMMATION SUMMIT

10-11-2025
BRISBANE, CALIF., NOV. 10, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS SUBMITS BIOLOGICS LICENSE APPLICATION TO U.S. FDA THROUGH ACCELERATED APPROVAL PROGRAM FOR ATACICEPT FOR THE TREATMENT OF ADULTS WITH IGA NEPHROPATHY

07-11-2025
ATACICEPT RECEIVED FDA BREAKTHROUGH THERAPY DESIGNATION FOR THE TREATMENT OF IGAN ORIGIN PHASE 3 TRI...
Více zde

VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

07-11-2025
BRISBANE, CALIF., NOV. 07, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS ANNOUNCES POSITIVE ORIGIN PHASE 3 DATA FOR ATACICEPT IN IGA NEPHROPATHY PRESENTED AT ASN KIDNEY WEEK 2025 AND PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE

06-11-2025
BRISBANE, CALIF., NOV. 06, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

05-11-2025
ORIGIN 3 TRIAL PRIMARY ENDPOINT RESULTS FOR ATACICEPT IN IGA NEPHROPATHY (IGAN) SELECTED AS A FEATUR...
Více zde

VERA THERAPEUTICS TO HOST AN INVESTOR CALL AND WEBCAST TO PROVIDE AN ORIGIN 3 UPDATE ON NOVEMBER 6, 2025 AT 4:30 PM ET

22-10-2025
BRISBANE, CALIF., OCT. 22, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS ANNOUNCES ORIGIN 3 LATE-BREAKING ABSTRACT SELECTED AS FEATURED ORAL PRESENTATION AT OPENING PLENARY SESSION OF ASN KIDNEY WEEK 2025

17-10-2025
BRISBANE, CALIF., OCT. 17, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-10-2025
BRISBANE, CALIF., OCT. 10, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

05-09-2025
BRISBANE, CALIF., SEPT. 05, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY AN...
Více zde

VERA THERAPEUTICS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES

26-08-2025
BRISBANE, CALIF., AUG. 26, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

08-08-2025
BRISBANE, CALIF., AUG. 08, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

05-08-2025
ON TRACK TO SUBMIT A BIOLOGICS LICENSE APPLICATION (BLA) FOR ACCELERATED APPROVAL OF ATACICEPT TO U....
Více zde

VERA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-07-2025
BRISBANE, CALIF. , JULY 10, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY AN...
Více zde

VERA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-06-2025
BRISBANE, CALIF., JUNE 09, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS TO PARTICIPATE IN THE GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

04-06-2025
BRISBANE, CALIF., JUNE 04, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA), A LATE C...
Více zde

VERA THERAPEUTICS ANNOUNCES REFINANCING OF EXISTING OXFORD DEBT FACILITY, PROVIDING UP TO $500 MILLION OF TERM LOANS

03-06-2025
BRISBANE, CALIF., JUNE 03, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (“VERA”), A LATE CLI...
Více zde

VERA THERAPEUTICS ANNOUNCES ATACICEPT ACHIEVED 46% PROTEINURIA REDUCTION IN ORIGIN PHASE 3 TRIAL IN ADULTS WITH IGA NEPHROPATHY

02-06-2025
BRISBANE, CALIF., JUNE 02, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANN...
Více zde

VERA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-05-2025
BRISBANE, CALIF., MAY 09, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY ANNO...
Více zde

VERA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

06-05-2025
ON TRACK TO ANNOUNCE THE PRIMARY ENDPOINT RESULTS FROM THE ATACICEPT PIVOTAL PHASE 3 ORIGIN TRIAL IN...
Více zde

VERA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-04-2025
BRISBANE, CALIF., APRIL 09, 2025 (GLOBE NEWSWIRE) -- VERA THERAPEUTICS, INC. (NASDAQ: VERA) TODAY AN...
Více zde

VERA THERAPEUTICS COMPLETES FULL ENROLLMENT IN PIVOTAL ORIGIN PHASE 3 TRIAL FOR ATACICEPT IN IGAN

03-04-2025
ON TRACK TO ANNOUNCE PRIMARY ENDPOINT RESULT FROM ORIGIN 3 TRIAL THIS QUARTER (2Q 2025) U.S. FDA BLA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-18 00:00:008-KStáhnout
2025-12-10 00:00:008-KStáhnout
2025-11-26 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-08-05 01:00:008-KStáhnout
2025-08-05 01:00:0010-QStáhnout
2025-08-05 00:00:008-KStáhnout
2025-08-05 00:00:0010-QStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-19 01:00:008-KStáhnout
2025-05-19 00:00:008-KStáhnout
2025-05-07 01:00:0010-QStáhnout
2025-05-07 00:00:0010-QStáhnout
2025-05-06 01:00:008-KStáhnout
2025-05-06 00:00:008-KStáhnout
2025-02-28 00:00:0010-KStáhnout
2025-02-27 23:00:0010-KStáhnout
2025-02-26 00:00:008-KStáhnout
2025-02-25 23:00:008-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-10-31 00:00:008-KStáhnout
2024-10-30 23:00:008-KStáhnout
2024-10-28 00:00:008-KStáhnout
2024-10-27 23:00:008-KStáhnout
2024-10-02 01:00:008-KStáhnout
2024-10-02 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-07-02 01:00:008-KStáhnout
2024-07-02 00:00:008-KStáhnout
2024-06-12 01:00:008-KStáhnout
2024-06-12 00:00:008-KStáhnout
2024-05-17 01:00:008-KStáhnout
2024-05-17 00:00:008-KStáhnout
2024-05-10 01:00:0010-QStáhnout
2024-05-10 00:00:0010-QStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 00:00:008-KStáhnout
2024-03-27 00:00:0010-KStáhnout
2024-03-26 23:00:0010-KStáhnout
2024-03-20 00:00:008-KStáhnout
2024-03-19 23:00:008-KStáhnout
2024-01-30 00:00:008-KStáhnout
2024-01-29 23:00:008-KStáhnout
2024-01-29 00:00:008-KStáhnout
2024-01-28 23:00:008-KStáhnout
2024-01-25 00:00:008-KStáhnout
2024-01-24 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-26 00:00:008-KStáhnout
2023-12-25 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-05-17 01:00:008-KStáhnout
2023-05-17 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-03-28 01:00:008-KStáhnout
2023-03-28 01:00:0010-KStáhnout
2023-03-28 00:00:008-KStáhnout
2023-03-28 00:00:0010-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-02-02 00:00:008-KStáhnout
2023-02-01 23:00:008-KStáhnout
2023-02-01 00:00:008-KStáhnout
2023-01-31 23:00:008-KStáhnout
2023-01-30 00:00:008-KStáhnout
2023-01-29 23:00:008-KStáhnout
2023-01-03 00:00:008-KStáhnout
2023-01-02 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-09-09 01:00:008-KStáhnout
2022-09-09 00:00:008-KStáhnout
2022-08-10 01:00:008-KStáhnout
2022-08-10 01:00:0010-QStáhnout
2022-08-10 00:00:008-KStáhnout
2022-08-10 00:00:0010-QStáhnout
2022-05-26 01:00:008-KStáhnout
2022-05-26 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 01:00:0010-QStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-16 00:00:0010-QStáhnout
2022-04-12 01:00:008-KStáhnout
2022-04-12 00:00:008-KStáhnout
2022-03-28 01:00:0010-KStáhnout
2022-03-28 00:00:0010-KStáhnout
2022-03-24 00:00:008-KStáhnout
2022-03-23 23:00:008-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-12-15 00:00:008-KStáhnout
2021-12-14 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-08-16 01:00:008-KStáhnout
2021-08-16 01:00:0010-QStáhnout
2021-08-16 00:00:008-KStáhnout
2021-08-16 00:00:0010-QStáhnout
2021-07-14 01:00:008-KStáhnout
2021-07-14 00:00:008-KStáhnout
2021-06-24 01:00:008-KStáhnout
2021-06-24 01:00:0010-QStáhnout
2021-06-24 00:00:008-KStáhnout
2021-06-24 00:00:0010-QStáhnout
2021-05-18 01:00:008-KStáhnout
2021-05-18 00:00:008-KStáhnout
preloader